SEC Form 4 · accession 0001125345-19-000018
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew K Fust
Director
Period of report
Feb 6, 2019
Accepted (ET)
Feb 8, 2019 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2019 | M | 6,924 | $20.15 | A | 7,424 | D | |
| Common StockF2 | Feb 6, 2019 | S | 6,924 | $29.38 | D | 500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $20.15 | Feb 6, 2019 | M | 6,924 | D | Jul 5, 2014 | Jun 5, 2024 | Common Stock | 6,924 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2018.
- F2The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $29.23 to $29.73. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.